June 2, 2009 - IDEAL LIFE Inc. and home care agency Bayada Nurses Inc. said today hospitalizations for patients using IDEAL LIFE’s remote health management products for congestive heart failure (CHF) and hypertension decreased 40 to 60 percent since the program began in September 2007.
June 2, 2009 - Cordex Pharma Inc. said today the FDA cleared the design of pivotal, phase 2b/3 clinical trials evaluating its lead product ATPace as an antiarrhytmic drug for the acute treatment of patients with paroxysmal supraventricular tachycardia (PSVT) under the special protocol assessment (SPA) process.
June 1, 2009 - Devax Inc. today said FDA has conditionally approved an investigational device exemption (IDE) for its AXXESS Biolimus A9-Eluting Bifurcation Stent System, allowing the company to initiate a pivotal clinical trial (DIVERGE II) of the device in the U.S.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
June 1, 2009 - Six months after placement of a vProtect Luminal Shield to treat a "vulnerable plaque,” a follow-up exam revealed reduced plaque burden and reduced stenosis in the target vessel.
June 1, 2009 - A new study shows about 2 percent of 18,165 patients undergoing cardiac catheterization had femoral vascular complications. The study conducted by the Bad Berka Central Clinic, Department of Cardiology in Germany, appears in the June 12 issue of the International Journal of Cardiology (Volume 135, June 12, 2009, Issue 1, Pages 66-71).
June 1, 2009 - Results and updates from eight studies were presented during a late-breaking trials session at Heart Failure 2009, May 30 – June 2 in Nice, France. Professor John McMurray, president of the Heart Failure Association, described the trials’ objectives and main implications.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 29, 2009 - Saint Francis Hospital in Evanston, Ill. has become the first hospital in Illinois to offer the new PRIME ECG made by Heartscape Technologies, which has a disposable vest containing 80 electrocardiogram leads that detect heart rhythm and blockages in 360-degrees of the heart.
May 29, 2009 - Celladon Corp. this week presented phase 1 data from the Calcium Up-Regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID), a first-in-human phase 1/2 clinical trial, in a scientific symposium at the 12th Annual American Society of Gene Therapy Meeting.
May 28, 2009 - Lantheus Medical Imaging Inc. has completed patient enrollment of CaRES (Contrast Echocardiography REgistry for Safety Surveillance), the first, multicenter Phase IV observational registry that evaluates the use of ultrasound imaging agents in routine clinical practice. The 1,060 patients who were enrolled at 15 sites in the U.S.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The Simbionix ANGIO Mentor family of cath lab simulators provide hands-on practice for multiple disciplines in an extensive and complete simulated environment of interventional endovascular procedures. Interventional cardiologists, interventional radiologists and vascular surgeons can use it to perform complete procedures, as well as acquiring basic skills.
May 28, 2009 - Boston Scientific Corp. said yesterday it received FDA clearance to market its TAXUS Liberte Atom Paclitaxel-Eluting Coronary Stent System, a next-generation drug-eluting stent (DES) specifically designed for treating small coronary vessels.
May 28, 2009 – Lantheus Medical Imaging Inc. today said it completed patient enrollment of CaRES (Contrast Echocardiography REgistry for Safety Surveillance), the first, multicenter phase IV observational registry that evaluates the use of ultrasound imaging agents in routine clinical practice.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
May 26, 2009 – HeartCare Cardiovascular Specialists in Libertyville, Ill. expanded its CVIS capabilities with a new DigiNet Pro system. This system will provide the site with Web access enabling users to have full CVIS capability from anywhere at anytime.
May 26, 2009 - ProSolv Cardiovascular, a Fujifilm company, this week released its Synapse ProSolv Cardiovascular version 4.0.2 software.
May 27, 2009 - Cytori completed enrollment in the first study to investigate adipose derived stem and regenerative cells in chronic heart disease.